Drug Type Small molecule drug |
Synonyms Itax, Itopride, Itopride Hydrochloridc + [18] |
Target |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors), D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (30 Jun 1995), |
Regulation- |
Molecular FormulaC20H27ClN2O4 |
InChIKeyZTOUXLLIPWWHSR-UHFFFAOYSA-N |
CAS Registry122892-31-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02729 | Itopride Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gastrointestinal Diseases | IN | 20 Jan 2003 | |
Chronic gastritis | JP | 30 Jun 1995 | |
Heart Failure | CN | - | - |
Hypertension | CN | - | - |
Nausea | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heartburn | Phase 3 | US | 01 Oct 2006 | |
Abdomen distended | Phase 3 | CA | 01 Jul 2004 | |
Dyspepsia | Phase 3 | CA | 01 Jul 2004 | |
Constipation | Phase 2 | PK | 01 Jun 2008 | |
Irritable bowel syndrome with constipation | Phase 2 | PK | 01 Jun 2008 | |
Diabetes Mellitus, Insulin-Dependent, 2 | Phase 2 | AU | 01 Mar 2005 | |
Gastroparesis | Phase 2 | AU | 01 Mar 2005 |
Not Applicable | - | ydnxvuqenq(lxfrgbnbaq) = asfbcissoq ynwnpmbsaz (bxidtzvkdt ) View more | - | 01 Jun 2005 | |||
Placebo | ydnxvuqenq(lxfrgbnbaq) = xatuzijtek ynwnpmbsaz (bxidtzvkdt ) View more |